Daclatasvir 30 mg/day is the correct dose for patients taking atazanavir/cobicistat-Reference-Cited by-同舟云学术

Daclatasvir 30 mg/day is the correct dose for patients taking atazanavir/cobicistat

Published:2016-10-20 Issue:2 Volume:72 Page:486-489
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:J. Antimicrob. Chemother.

Author:

Smolders E. J.,Colbers E. P. H.,de Kanter C. T. M. M.,Velthoven-Graafland K.,Drenth J. P. H.,Burger D. M.

Funder

Bristol-Myers Squibb Pharma EEIG

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/72/2/486/9684039/dkw429.pdf

Reference19 articles.

1. Viral hepatitis and HIV coinfection

2. World Health Organization. WHO Factsheet. HIV/AIDS . http://www.who.int/mediacentre/factsheets/fs360/en/ .

3. FDA. Reyataz: Prescribing Information . http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206352s003,021567s038lbl.pdf .

4. EMA. Norvir: Summary of Product Characteristics . http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000127/WC500028728.pdf .

5. EMA. Stribild: Summary of Product Characteristics . http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002574/WC500144272.pdf .

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of CYPs and Transporters in the Biotransformation and Transport of the Anti-hepatitis C Antiviral Agents Asunaprevir, Daclatasvir, and Beclabuvir: Impact of Liver Disease, Race and Drug-drug Interactions on Safety and Efficacy;Current Drug Metabolism;2024-02

2. Review: Evaluation and Management of the HIV/HCV Co-Infected Kidney or Liver Transplant Candidate;CURR TREAT OPT INFEC;2020

3. Viral Hepatitis C Therapy: Pharmacokinetic and Pharmacodynamic Considerations: A 2019 Update;Clinical Pharmacokinetics;2019-05-21

4. An update on the management of hepatitis C virus and human immunodeficiency virus co-infection;Future Virology;2019-03

5. Viral Hepatitis;Clinical Gastroenterology;2019